MedTrace Logo

Prognosis of Treated Acute Coronary Syndrome Patients: a Multicenter Study

NCT05164601 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 22500

Last updated 2025-02-04

No results posted yet for this study

Summary

The MPCS-ACS Study (Multicenter Prospective Cohort Study on Acute Coronary Syndrome) is a comprehensive, forward-looking research project designed to evaluate the prognostic outcomes of patients diagnosed with acute coronary syndrome (ACS) who declined coronary artery bypass grafting (CABG) and underwent percutaneous coronary intervention (PCI) instead. Leveraging a multicenter approach, the study aims to collect data from a diverse patient population, thereby enhancing the generalizability and clinical relevance of its findings.

Upon enrollment, detailed information is gathered, including demographic data, clinical history, and key biochemical markers. The study also documents the various medication regimens prescribed during hospitalization to assess their influence on patient outcomes. A key feature of MPCS-ACS is its rigorous follow-up protocol, which involves regularly monitoring patients after discharge to track recovery progress and the occurrence of any subsequent cardiovascular events.

This methodical approach is designed to generate valuable insights into the long-term prognosis of ACS patients treated with PCI, ultimately contributing to the refinement of therapeutic strategies and improving the standard of care across all participating centers.

Conditions

  • Acute Coronary Syndrome

Interventions

OTHER

No Intervention - Observational Only

Clinical Follow-Up

Sponsors & Collaborators

  • Affiliated Traditional Chinese Medicine Hospital of Xinjiang Medical University

    collaborator UNKNOWN

  • The Third Affiliated Hospital of Jinzhou Medical University

    collaborator UNKNOWN

  • Xiang Xie

    lead OTHER

Principal Investigators

  • Xiang Xie, PhD · Xinjiang Medical University

Eligibility

Min Age
18 Years
Max Age
79 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-06-01
Primary Completion
2021-05-31
Completion
2023-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05164601 on ClinicalTrials.gov